Inmune Bio, Inc. — Director's Dealing 2019

Jun 4, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Inmune Bio, Inc. (INMB)
CIK: 0001711754
Period of Report: 2019-06-03-06:00

Reporting Person: Juda Scott (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-06-03-06:00	Common Stock	P	10000	$6	Acquired	22500	Direct

Footnotes

F1: The Reporting Person purchased 10,000 shares of the Issuer's common stock from an existing shareholder in a private transaction.